Newly released data from lactoferrin market analysis by Future Market Insights shows that global consumption of lactoferrin enjoyed year-on-year (YoY) growth of 5.0% in 2021 to total sales of US$ 192.8 Mn in the year. The overall demand for lactoferrin captivates 33% of the global milk ingredients market and is poised to witness a prominent growth at 5.6% CAGR to reach the value of US$ 332.2 Mn in 2031.
Lactoferrin, being a natural protein, derived from cow milk, which is also known as the main milk ingredient found in the breast milk protein, can be used as an alternative for lactose supplements.
Applications of lactoferrin on milk nutrition segment is poised among the leader for both growth-wise and share-wise, having antimicrobial characteristics which can protect the human body against numerous pathogens. Lactoferrin is also considered a cationic glycoprotein, being used as a nutritional ingredient in different food & beverage products, such as food supplements, non-alcoholic beverages, and sports nutrition products.
Get | Download Sample Copy with Graphs & List of Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-11070
Key Takeaways from the Lactoferrin Market Study:
- Europe lactoferrin production is leading in terms of market share and accounts for 31.1% of the global lactoferrin market in 2021 exhibiting high demand for the product with the presence of leading manufacturers in the region.
- Powdered lactoferrin is the dominant form in the lactoferrin industry, as the shelf life of the product is more when compared to the liquid form, thus the powdered form is easy to store and lasts a little longer. The powdered form is accounting for a market share of 88.9% in 2021 of the global market.
- In the application segment, the use of the product in clinical nutrition is anticipated to witness a lucrative growth rate with a CAGR of 7.3% during the forecast period (2021-2031) in the lactoferrin market.
- However, application in infant formulas holds the highest market share, worth 35.9% of the global share as of 2021, because of the huge demand for baby food supplements.
- In the South Asia region, demand for lactoferrin is booming with a high CAGR worth 7.7%, as a result of high awareness of the product as a dietary supplement.
Lactoferrin is an intact protein that consists of 696 basic (positively charged) amino acids with an abundant nutritional value. As a result, the US Food and Drug Administration (FDA) has identified lactoferrin, derived from cow milk, as a GRAS (Generally Recognised as Safe) ingredient for functional foods and sports nutrition supplements. The agency even gave the same definition to lactoferrin in 2014, which can be used in dairy products and infant formulas.
Who is winning?
The future of lactoferrin adoption depends on the F&B companies, especially brands making baby foods and dietary supplements, who are motivated to comply with the food safety certification requirements and necessary environmental standards. As a result, more innovation across the value chain is required to increase the adoption rate of the product, driven by a new food revolution generated through consumer tastes and preferences while leveraging automation effectively.
Some of the leading companies offering lactoferrin are Vitalus Nutrition Inc., Glanbia plc, Milei Gmbh, NutriScience, Nestle SA, Pharming Group NV, Farbest Brands, Bega Cheese Group, Fonterra Co-operative Group Ltd and InVitria, and others.
Lactoferrin by Category
By form :
By application :
- Sports Nutrition
- Infant Formulas
- Clinical Nutrition
- Veterinary Nutrition
- Personal Care
- Food Nutrition
By region :
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa
Key Questions Answered in the Report
Worth how much sales of lactoferrin are expected in the current scenario?
The sales for lactoferrin are estimated to be worth over US$ 192.8 Mn by 2021.
What was the demand outlook for lactoferrin in the historical period?
According to the research, the demand outlook for lactoferrin was estimated to be 4.2% for the period between 2016 and 2020.
What will be the next 10-year adoption rate of lactoferrin?
Between 2021 and 2031, the adoption rate of lactoferrin will grow at 5.6% CAGR.
Who are the top 5 players navigating the production of lactoferrin?
Glanbia plc, Vitalus Nutrition Inc., NutriScience, Milei Gmbh, and Nestle SA are the leading companies navigating the growth of the product.
What are the top 5 countries driving the consumption of lactoferrin?
U.S., Australia, China, Brazil, and India are the top countries reflecting the consistently high demand for the product.
At what rate is the lactoferrin shipment occurring in North America?
North America is operating shipment of the product with a 5.4% CAGR through 2031.
What is the sales outlook of lactoferrin in Europe?
Europe will grow in sales of the product with a 4.7% CAGR through the assessment period.
Can lactoferrin prevent Covid-19?
According to the researchers of University of Huddersfield, antiviral effects of lactoferrin gives the product a great quality of a natural supplement, which may be used for Respiratory Tract Infections (RTIs), as well as an adjunct for Covid-19.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]